Literature DB >> 16932399

Drug-associated renal dysfunction and injury.

Devasmita Choudhury1, Ziauddin Ahmed.   

Abstract

Renal dysfunction and injury secondary to medications are common, and can present as subtle injury and/or overt renal failure. Some drugs perturb renal perfusion and induce loss of filtration capacity. Others directly injure vascular, tubular, glomerular and interstitial cells, such that specific loss of renal function leads to clinical findings, including microangiopathy, Fanconi syndrome, acute tubular necrosis, acute interstitial nephritis, nephrotic syndrome, obstruction, nephrogenic diabetes insipidus, electrolyte abnormalities and chronic renal failure. Understanding the mechanisms involved, and recognizing the clinical presentations of renal dysfunction arising from use of commonly prescribed medications, are important if injury is to be detected early and prevented. This article reviews the clinical features and basic processes underlying renal injury related to the use of common drugs.

Entities:  

Mesh:

Year:  2006        PMID: 16932399     DOI: 10.1038/ncpneph0076

Source DB:  PubMed          Journal:  Nat Clin Pract Nephrol        ISSN: 1745-8323


  62 in total

1.  Safe administration of celecoxib to a patient with repeated episodes of nephrotic syndrome induced by NSAIDs.

Authors:  Karlo Mihovilovic; Danica Ljubanovic; Mladen Knotek
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

Review 2.  Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles.

Authors:  Ahsan N Rizwan; Gerhard Burckhardt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

3.  Cytoplasmic initiation of cisplatin cytotoxicity.

Authors:  Fang Yu; Judit Megyesi; Peter M Price
Journal:  Am J Physiol Renal Physiol       Date:  2008-04-09

4.  [Turnaround time for reporting results of radiological examinations in intensive care unit patients: an internal quality control].

Authors:  L Albrecht; R Busse; H Tepe; R Poschmann; U Teichgräber; B Hamm; M de Bucourt
Journal:  Radiologe       Date:  2013-09       Impact factor: 0.635

Review 5.  Mechanisms of antimicrobial-induced nephrotoxicity in children.

Authors:  Kevin J Downes; Molly Hayes; Julie C Fitzgerald; Gwendolyn M Pais; Jiajun Liu; Nicole R Zane; Stuart L Goldstein; Marc H Scheetz; Athena F Zuppa
Journal:  J Antimicrob Chemother       Date:  2020-01-01       Impact factor: 5.790

6.  Analysis of renal function during telaprevir-based triple therapy for chronic hepatitis C.

Authors:  Motoyuki Kohjima; Miho Kurokawa; Munechika Enjoji; Tsuyoshi Yoshimoto; Tsukasa Nakamura; Tomoko Ohashi; Kunitaka Fukuizumi; Naohiko Harada; Yusuke Murata; Kazuhisa Matsunaga; Masaki Kato; Kazuhiro Kotoh; Makoto Nakamuta
Journal:  Exp Ther Med       Date:  2016-03-09       Impact factor: 2.447

7.  A Systems Toxicology Approach for the Prediction of Kidney Toxicity and Its Mechanisms In Vitro.

Authors:  Susanne Ramm; Petar Todorov; Vidya Chandrasekaran; Anders Dohlman; Maria B Monteiro; Mira Pavkovic; Jeremy Muhlich; Harish Shankaran; William W Chen; Jerome T Mettetal; Vishal S Vaidya
Journal:  Toxicol Sci       Date:  2019-05-01       Impact factor: 4.849

8.  Safety of Extended Interval Tobramycin in Cystic Fibrosis Patients Less an 6 Years Old.

Authors:  Alexandria Arends; Rebecca Pettit
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Mar-Apr

9.  Targeted therapy of colorectal neoplasia with rapamycin in peptide-labeled pegylated octadecyl lithocholate micelles.

Authors:  Supang Khondee; Emily F Rabinsky; Scott R Owens; Bishnu P Joshi; Zhen Qiu; Xiyu Duan; Lili Zhao; Thomas D Wang
Journal:  J Control Release       Date:  2014-12-04       Impact factor: 9.776

Review 10.  Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease.

Authors:  Cécile Caubet; Chrystelle Lacroix; Stéphane Decramer; Jens Drube; Jochen H H Ehrich; Harald Mischak; Jean-Loup Bascands; Joost P Schanstra
Journal:  Pediatr Nephrol       Date:  2009-07-15       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.